These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2936703)

  • 1. Genetic control of HLA-linked immune responsiveness to (H,G)-A-L.
    Katz D; Suez D; Brautbar C; Cohen T; Bentwich Z; Mozes E
    Hum Immunol; 1986 Jan; 15(1):75-84. PubMed ID: 2936703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic control of immune response to the L-Glu, L-Lys, L-Phe terpolymer in man.
    Chan MM; Bias WB; Hsu SH; Meyers DA
    Am J Hum Genet; 1985 May; 37(3):561-70. PubMed ID: 3923830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-linked immune responsiveness to (T,G)-A-L: a family study.
    Suez D; Katz D; Brautbar C; Cohen T; Weisman Z; Bentwich Z; Mozes E
    Hum Immunol; 1985 Aug; 13(4):219-34. PubMed ID: 4040901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immune response to (T,G)-A-L and GAT in man: an association of nonresponsiveness to (T,G)-A-L with HLA-DRw8.
    Hensen EJ; Elferink D
    Hum Immunol; 1984 Jun; 10(2):113-27. PubMed ID: 6429091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic control of major histocompatibility complex-linked immune responses to synthetic polypeptides in man: poly(L-phenylalanine, L-glutamic acid)-poly (DL-alanine)--poly(L-lysine) and L-glutamic acid, L-alanine, L-tyrosine (60:30:10).
    Chan MM; Bias WB; Hsu SH; Meyers DA
    Proc Natl Acad Sci U S A; 1984 Jun; 81(11):3521-5. PubMed ID: 6427771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (T,G)-A-L specific immune response potential and HLA typing of Israeli patients with systemic lupus erythematosus.
    Shalev Y; Bentwich Z; Katz D; Brautbar C; Mozes E
    Clin Exp Immunol; 1985 May; 60(2):355-62. PubMed ID: 2408803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen specific immune response potential and HLA typing of Israeli patients with thyroid autoimmune diseases (TAD).
    Shalev Y; Bentwich Z; Katz D; Brautbar C; Mozes E
    Clin Exp Immunol; 1986 May; 64(2):255-60. PubMed ID: 2427266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of antigen specific T cell helper function in first degree relatives of patients with systemic lupus erythematosus (SLE).
    Segal R; Brautbar C; Katz D; Shalev Y; Bentwich Z; Mozes E
    Clin Exp Immunol; 1986 Oct; 66(1):52-60. PubMed ID: 2433083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic control of major histocompatibility complex-linked immune responses to synthetic polypeptides in man.
    Hsu SH; Chan MM; Bias WB
    Proc Natl Acad Sci U S A; 1981 Jan; 78(1):440-4. PubMed ID: 6787587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of insulin-dependent diabetes-new evidence.
    Dunsworth TS; Rich SS; Morton NE; Barbosa J
    Clin Genet; 1982 Apr; 21(4):233-6. PubMed ID: 6955075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immune response to hepatitis B vaccine in humans: inheritance patterns in families.
    Kruskall MS; Alper CA; Awdeh Z; Yunis EJ; Marcus-Bagley D
    J Exp Med; 1992 Feb; 175(2):495-502. PubMed ID: 1531063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of HLA and immune responses to bovine collagen implants.
    Vanderveen EE; McCoy JP; Schade W; Kapur JJ; Hamilton T; Ragsdale C; Grekin RC; Swanson NA
    Arch Dermatol; 1986 Jun; 122(6):650-4. PubMed ID: 2424374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA class II restriction governing cell cooperation between antigen-specific helper T lymphocytes, B lymphocytes and monocytes for in vitro antibody production to influenza virus.
    Fischer A; Sterkers G; Charron D; Durandy A
    Eur J Immunol; 1985 Jun; 15(6):620-6. PubMed ID: 3159585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the peptide model of allorecognition: cytotoxic T lymphocytes recognize an alloantigen encoded by two HLA-linked genes.
    Schendel DJ
    Hum Immunol; 1990 Mar; 27(3):229-39. PubMed ID: 2341303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histocompatibility antigens in polymyalgia rheumatica and giant cell arteritis.
    Armstrong RD; Behn A; Myles A; Panayi GS; Welsh KI
    J Rheumatol; 1983 Aug; 10(4):659-61. PubMed ID: 6413689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular localization and polymorphism of HLA class II restriction determinants defined by Mycobacterium leprae-reactive helper T cell clones from leprosy patients.
    Ottenhoff TH; Neuteboom S; Elferink DG; de Vries RR
    J Exp Med; 1986 Dec; 164(6):1923-39. PubMed ID: 2431092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A human melanoma cell line, recognized by both HLA class I and class II restricted T cells, is capable of initiating both primary and secondary immune responses.
    Olsen AC; Fossum B; Kirkin AF; Zeuthen J; Gaudernack G
    Scand J Immunol; 1995 Apr; 41(4):357-64. PubMed ID: 7899823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA genotypes in two three-generation families with rheumatoid arthritis.
    Ström H; Dahlqvist SR; Bjelle A; Möller E
    Hum Immunol; 1985 Aug; 13(4):243-51. PubMed ID: 3928542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-linked immune suppression genes.
    Sasazuki T
    Jinrui Idengaku Zasshi; 1990 Mar; 35(1):1-13. PubMed ID: 2142511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation.
    Pei J; Martin PJ; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J
    Biol Blood Marrow Transplant; 1997 Aug; 3(3):142-9. PubMed ID: 9310191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.